MODIFIED CMV GB PROTEIN AND CMV VACCINE INCLUDING SAME
2021
Online
Patent
The present invention is directed to provide a modified CMV gB protein that can induce a group of antibodies including a high ratio of neutralizing antibodies that exhibit a high neutralizing activity against a CMV gB protein, in comparison with a wild type CMV gB, upon induction of immunity and that can be used in the prevention and/or treatment of CMV infection and a CMV vaccine comprising the modified CMV gB protein. The modified CMV gB protein according to the present invention is a modified CMV gB protein having an improved ability to induce body region-recognizing antibodies and comprising modification in a head region.
Titel: |
MODIFIED CMV GB PROTEIN AND CMV VACCINE INCLUDING SAME
|
---|---|
Link: | |
Veröffentlichung: | 2021 |
Medientyp: | Patent |
Sonstiges: |
|